Colorectal Cancer Clinical Trials in Arizona

Showing 221-240 of 242 trials

Study of CS-1008 in Combination With FOLFIRI in Patients Who Have Failed Other Treatments

NCT01124630

Treatment with CS-1008 in combination with FOLFIRI (irinotecan, leucovorin, and 5-fluorouracil \[5-FU\]) in subjects with metastatic colorectal cancer (CRC) who have failed first-line treatment that was not irinotecan-based.

Metastatic Colorectal Cancer

Daiichi Sankyo21 participantsStarted May 2010

Scottsdale, Arizona, United States • Jacksonville, Florida, United States • Rochester, Minnesota, United States

COMPLETEDPhase 231 miles

Combination Chemotherapy Plus Bevacizumab in Treating Patients With Advanced Colorectal Cancer

NCT00006786

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Bevacizumab may stop the growth of colorectal cancer by stopping blood flow to the tumor. PURPOSE: Phase II trial to study the effectiveness of combination chemotherapy plus bevacizumab in treating patients who have advanced colorectal cancer.

Colorectal Cancer

Eastern Cooperative Oncology GroupStarted Nov 2000

Scottsdale, Arizona, United States • Duarte, California, United States • Palo Alto, California, United States +74 more locations

Study of CS-1008 in Combination With FOLFIRI in Patients Who Have Failed Other Treatments

Combination Chemotherapy Plus Bevacizumab in Treating Patients With Advanced Colorectal Cancer

Colorectal Cancer Trials in Other Cities

Study of XL281 in Adults With Solid Tumors

Safety and Effectiveness Study of Autologous Natural Killer and Natural Killer T Cells on Cancer

FR901228 in Treating Patients With Previously Treated Unresectable Locally Advanced or Metastatic Colorectal Cancer

SWOG-S9635 Fluorouracil Plus Ethynyluracil in Advanced Colorectal Cancer Not Responded to Fluorouracil

Irinotecan With or Without Oxaliplatin in Treating Patients With Metastatic Colorectal Cancer

Fluorouracil and Leucovorin With or Without Oxaliplatin in Treating Patients With Recurrent Metastatic Colorectal Cancer

DHA-Paclitaxel in Treating Patients With Metastatic Colorectal Cancer

Phase III Randomized Study of 5-FU, CoFactor, and Avastin vs. 5-FU, LV and Avastin for First-Line Colorectal Cancer.

Combination Chemotherapy Before or After Surgery in Treating Patients With Colorectal Cancer With Liver Metastases That Could Be Removed By Surgery

Patient-Reported Outcomes in Long-Term Survivors of Colon and Rectal Cancers

A Study Comparing Oral Picoplatin With Intravenous Picoplatin in Subjects With Solid Tumors

Oxaliplatin and Capecitabine With or Without an Hepatic Arterial Infusion With Floxuridine in Treating Patients Who Are Undergoing Surgery and/or Ablation for Liver Metastases Due to Colorectal Cancer

Comparison of Barium Enema, Computed Tomographic Colonography, and Colonoscopy in Detecting Colon Cancer

Computerized Tomographic Colonography Compared With Standard Diagnostic Procedures in Detecting Colorectal Neoplasia

Monoclonal Antibody ABX-EGF in Treating Patients With Renal (Kidney), Prostate, Pancreatic, Non-Small Cell Lung, Colon or Rectal, Esophageal, or Gastroesophageal Junction Cancer

S9923 R115777 in Treating Patients With Advanced Colorectal Cancer

A Study of ABT-751 in Patients With Colorectal Cancer

Phase 2 Study of ABT-869 in Combination With mFOLFOX6 Versus Bevacizumab in Combination With mFOLFOX6 to Treat Advanced Colorectal Cancer

Other Conditions in Arizona